1. Home
  2. RFL vs BEAT Comparison

RFL vs BEAT Comparison

Compare RFL & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BEAT
  • Stock Information
  • Founded
  • RFL 2017
  • BEAT 2015
  • Country
  • RFL United States
  • BEAT United States
  • Employees
  • RFL 31
  • BEAT N/A
  • Industry
  • RFL Real Estate
  • BEAT Retail: Computer Software & Peripheral Equipment
  • Sector
  • RFL Finance
  • BEAT Technology
  • Exchange
  • RFL Nasdaq
  • BEAT Nasdaq
  • Market Cap
  • RFL 67.7M
  • BEAT 51.1M
  • IPO Year
  • RFL N/A
  • BEAT 2021
  • Fundamental
  • Price
  • RFL $1.90
  • BEAT $1.29
  • Analyst Decision
  • RFL
  • BEAT Buy
  • Analyst Count
  • RFL 0
  • BEAT 1
  • Target Price
  • RFL N/A
  • BEAT $8.00
  • AVG Volume (30 Days)
  • RFL 440.7K
  • BEAT 158.9K
  • Earning Date
  • RFL 06-11-2025
  • BEAT 08-13-2025
  • Dividend Yield
  • RFL N/A
  • BEAT N/A
  • EPS Growth
  • RFL N/A
  • BEAT N/A
  • EPS
  • RFL N/A
  • BEAT N/A
  • Revenue
  • RFL $732,000.00
  • BEAT N/A
  • Revenue This Year
  • RFL N/A
  • BEAT N/A
  • Revenue Next Year
  • RFL N/A
  • BEAT N/A
  • P/E Ratio
  • RFL N/A
  • BEAT N/A
  • Revenue Growth
  • RFL 35.56
  • BEAT N/A
  • 52 Week Low
  • RFL $1.27
  • BEAT $1.17
  • 52 Week High
  • RFL $3.19
  • BEAT $3.48
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.05
  • BEAT 36.52
  • Support Level
  • RFL $1.81
  • BEAT $1.17
  • Resistance Level
  • RFL $2.04
  • BEAT $1.37
  • Average True Range (ATR)
  • RFL 0.16
  • BEAT 0.10
  • MACD
  • RFL 0.00
  • BEAT -0.01
  • Stochastic Oscillator
  • RFL 71.43
  • BEAT 26.67

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: